180 related articles for article (PubMed ID: 35266035)
1. Adolescent THC exposure: effects on pain-related, exploratory, and consummatory behaviors in adult male vs. female rats.
Gogulski HY; Craft RM
Psychopharmacology (Berl); 2022 May; 239(5):1563-1578. PubMed ID: 35266035
[TBL] [Abstract][Full Text] [Related]
2. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
Morris T; Cucinello-Ragland JA; Marks TJ; Prevost K; Glenn JF; Davenport GJ; Edwards S; Winsauer PJ
Pharmacol Biochem Behav; 2024 Feb; 235():173692. PubMed ID: 38128766
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
[TBL] [Abstract][Full Text] [Related]
4. No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.
Britch SC; Craft RM
Behav Pharmacol; 2021 Dec; 32(8):630-639. PubMed ID: 34561365
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
Craft RM; Kandasamy R; Davis SM
Pain; 2013 Sep; 154(9):1709-1717. PubMed ID: 23707295
[TBL] [Abstract][Full Text] [Related]
6. Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ
Henderson-Redmond AN; Sepulveda DE; Ferguson EL; Kline AM; Piscura MK; Morgan DJ
Psychopharmacology (Berl); 2022 May; 239(5):1289-1309. PubMed ID: 34165606
[TBL] [Abstract][Full Text] [Related]
7. Intravenous self-administration of delta-9-THC in adolescent rats produces long-lasting alterations in behavior and receptor protein expression.
Stringfield SJ; Torregrossa MM
Psychopharmacology (Berl); 2021 Jan; 238(1):305-319. PubMed ID: 33111197
[TBL] [Abstract][Full Text] [Related]
8. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat.
Wakley AA; Wiley JL; Craft RM
Drug Alcohol Depend; 2014 Oct; 143():22-8. PubMed ID: 25131716
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in acute delta-9-tetrahydrocannabinol (Δ
Lulek CF; Maulik M; Mitra S; Guindon J; Morgan DJ; Henderson-Redmond AN
Psychopharmacology (Berl); 2023 Sep; 240(9):1987-2003. PubMed ID: 37516707
[TBL] [Abstract][Full Text] [Related]
11. Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats.
García-Gil L; De Miguel R; Muñoz RM; Cebeira M; Villanua MA; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1997; 19(6):477-87. PubMed ID: 9392783
[TBL] [Abstract][Full Text] [Related]
12. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
Houser SJ; Eads M; Embrey JP; Welch SP
Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
[TBL] [Abstract][Full Text] [Related]
13. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
Wakley AA; Wiley JL; Craft RM
Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
[TBL] [Abstract][Full Text] [Related]
14. Analgesia by intrathecal delta-9-tetrahydrocannabinol is dependent on Cav3.2 calcium channels.
Gadotti VM; Antunes FTT; Zamponi GW
Mol Brain; 2023 May; 16(1):47. PubMed ID: 37231418
[TBL] [Abstract][Full Text] [Related]
15. Persistent Exposure to Δ
Mabou Tagne A; Fotio Y; Ibne Rashid T; Piomelli D
J Pharmacol Exp Ther; 2021 Sep; 378(3):215-221. PubMed ID: 34183435
[TBL] [Abstract][Full Text] [Related]
16. Gonadal hormone modulation of ∆
Craft RM; Haas AE; Wiley JL; Yu Z; Clowers BH
Pharmacol Biochem Behav; 2017 Jan; 152():36-43. PubMed ID: 27670094
[TBL] [Abstract][Full Text] [Related]
17. Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.
Scherma M; Dessì C; Muntoni AL; Lecca S; Satta V; Luchicchi A; Pistis M; Panlilio LV; Fattore L; Goldberg SR; Fratta W; Fadda P
Neuropsychopharmacology; 2016 Apr; 41(5):1416-26. PubMed ID: 26388146
[TBL] [Abstract][Full Text] [Related]
18. Vaporized cannabis extract-induced antinociception in male vs female rats with persistent inflammatory pain.
Craft RM; Gogulski HY; Freels TG; Glodosky NC; McLaughlin RJ
Pain; 2023 Sep; 164(9):2036-2047. PubMed ID: 37027147
[TBL] [Abstract][Full Text] [Related]
19. In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers.
Schindler EAD; Schnakenberg Martin AM; Sewell RA; Ranganathan M; DeForest A; Pittman BP; Perrino A; D'Souza DC
Psychopharmacology (Berl); 2020 Oct; 237(10):3097-3107. PubMed ID: 32632491
[TBL] [Abstract][Full Text] [Related]
20. Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.
Suplita RL; Eisenstein SA; Neely MH; Moise AM; Hohmann AG
Neuropharmacology; 2008 Jan; 54(1):161-71. PubMed ID: 17714742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
